Ipratropium Bromide NDC 72162-2144

NDC codes

FDA NDC Directory

Product NDC (as listed)72162-2144Labeler and product segments. Claims need a package NDC.

Product NDC at billing width72162-2144Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
72162-2144-2	72162214402	1 BOTTLE, SPRAY in 1 CARTON (72162-2144-2) / 165 SPRAY in 1 BOTTLE, SPRAYMarketed from Dec 7, 2023

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Ipratropium Bromide
Generic name (nonproprietary): ipratropium bromide
Active ingredients: Ipratropium bromide — 42 ug/1
Dosage form: Spray
Route: Nasal
Labeler: Bryant Ranch Prepack
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 076598
Marketing start: Nov 5, 2003
Listing expires: Dec 31, 2026
Other FDA classes: Cholinergic Antagonists (Mechanism)
Identifiers: Product ID 72162-2144_62a2d09a-885e-4b77-be25-e68d409e5db6SPL ID 62a2d09a-885e-4b77-be25-e68d409e5db6SPL set ID 43ef9085-64e4-429a-a614-926d9a3652b7RxCUI 1797844UNII J697UZ2A9J
Pharmacologic class: Anticholinergic

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Nasal products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N472162214402 followed by a unit qualifier and the quantity

Package 72162-2144-02. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Nov 8, 2024.

Indications (excerpt from the label)

INDICATIONS AND USAGE Ipratropium bromide nasal solution 0.06% is indicated for the symptomatic relief of rhinorrhea associated with the common cold or seasonal allergic rhinitis for adults and children age 5 years and older. Ipratropium bromide 0.06% does not relieve nasal congestion or sneezing associated with the common cold or seasonal allergic rhinitis. The safety and effectiveness of the use of ipratropium bromide 0.06% beyond four days in patients with the common cold or beyond three weeks in patients with seasonal allergic rhinitis has not been established.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 076598

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 076598
Product	Strength	Form · route	Labeler	Product NDC
Ipratropium Bromide	Ipratropium bromide 42 ug/1	SprayNasal	Hikma Pharmaceuticals USA Inc.	0054-0046